Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Omeros Corp
(NQ:
OMER
)
10.91
+3.18 (+41.14%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,068,714
Open
7.700
Bid (Size)
10.76 (2)
Ask (Size)
11.00 (3)
Prev. Close
7.730
Today's Range
7.460 - 10.99
52wk Range
1.811 - 10.99
Shares Outstanding
62,855,824
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
November 22, 2024
Via
Benzinga
Omeros Corporation Provides Update on Progress Toward BLA Resubmission
November 21, 2024
From
Omeros Corporation
Via
Business Wire
Performance
YTD
+231.61%
+231.61%
1 Month
+164.16%
+164.16%
3 Month
+157.31%
+157.31%
6 Month
+225.67%
+225.67%
1 Year
+492.93%
+492.93%
More News
Read More
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
November 18, 2024
Via
Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
Earnings Outlook For Omeros
November 12, 2024
Via
Benzinga
OMER Stock Earnings: Omeros Misses EPS for Q2 2024
August 07, 2024
Via
InvestorPlace
OMER Stock Earnings: Omeros Misses EPS for Q1 2024
May 15, 2024
Via
InvestorPlace
Omeros Corporation Reports Third Quarter 2024 Financial Results
November 13, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
November 11, 2024
From
Omeros Corporation
Via
Business Wire
FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
October 24, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation Reports Second Quarter 2024 Financial Results
August 07, 2024
From
Omeros Corporation
Via
Business Wire
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
April 01, 2024
Via
InvestorPlace
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
August 05, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Announces Webcast Details for Annual Meeting of Shareholders
June 04, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
June 03, 2024
From
Omeros Corporation
Via
Business Wire
Crude Oil Moves Higher; Deere Cuts Profit Outlook
May 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 16, 2024
Via
Benzinga
US Stocks Edge Higher; Initial Jobless Claims Fall
May 16, 2024
Via
Benzinga
Omeros Corporation Reports First Quarter 2024 Financial Results
May 15, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
May 10, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
May 09, 2024
From
Omeros Corporation
Via
Business Wire
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
April 01, 2024
From
Omeros Corporation
Via
Business Wire
Earnings Scheduled For April 1, 2024
April 01, 2024
Via
Benzinga
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
April 01, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.